Literature DB >> 9445003

Neuronal cell surface molecules mediate specific binding to rabies virus glycoprotein expressed by a recombinant baculovirus on the surfaces of lepidopteran cells.

C Tuffereau1, J Benejean, A M Alfonso, A Flamand, M C Fishman.   

Abstract

The existence of specific rabies virus (RV) glycoprotein (G) binding sites on the surfaces of neuroblastoma cells is demonstrated. Spodoptera frugiperda (Sf21) cells expressing G of the RV strain CVS (Gcvs-Sf21 cells) bind specifically to neuroblastoma cells of different species but not to any other cell type (fibroblast, myoblast, epithelial, or glioma). Attachment to mouse neuroblastoma NG108-15 cells is abolished by previous treatment of Gcvs-Sf2 cells with anti-G antibody. Substitutions for lysine at position 330 and for arginine at position 333 in RV G greatly reduce interaction between Gcvs-Sf21 cells and NG108-15 cells. These data are consistent with in vivo results: an avirulent RV mutant bearing the same double mutation is not able to infect sensory neurons or motoneurons (P. Coulon, J.-P. Ternaux, A. Flamand, and C. Tuffereau, J. Virol. 72:273-278, 1998) after intramuscular inoculation into a mouse. Furthermore, infection of NG108-15 cells by RV but not by vesicular stomatitis virus leads to a reduction of the number of binding sites at the neuronal-cell surface. Our data strongly suggest that these specific attachment sites on neuroblastoma cells represent a neuronal receptor(s) used by RV to infect certain types of neurons in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445003      PMCID: PMC124581     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro.

Authors:  P Coulon; J P Ternaux; A Flamand; C Tuffereau
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

2.  Inhibition of rabies virus infection by a soluble membrane fraction from the rat central nervous system.

Authors:  C Conti; B Hauttecoeur; M J Morelec; B Bizzini; N Orsi; H Tsiang
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Membrane carbohydrate requirement for rabies virus binding to chicken embryo related cells.

Authors:  C Conti; F Superti; H Tsiang
Journal:  Intervirology       Date:  1986       Impact factor: 1.763

4.  Neuronal traits of clonal cell lines derived by fusion of dorsal root ganglia neurons with neuroblastoma cells.

Authors:  D Platika; M H Boulos; L Baizer; M C Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro.

Authors:  B Dietzschold; T J Wiktor; J Q Trojanowski; R I Macfarlan; W H Wunner; M J Torres-Anjel; H Koprowski
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

6.  Binding of rabies virus to purified Torpedo acetylcholine receptor.

Authors:  T L Lentz; R J Benson; D Klimowicz; P T Wilson; E Hawrot
Journal:  Brain Res       Date:  1986-12       Impact factor: 3.252

7.  Involvement of gangliosides in rabies virus infection.

Authors:  F Superti; B Hauttecoeur; M J Morelec; P Goldoni; B Bizzini; H Tsiang
Journal:  J Gen Virol       Date:  1986-01       Impact factor: 3.891

8.  Rabies virus binding at neuromuscular junctions.

Authors:  T G Burrage; G H Tignor; A L Smith
Journal:  Virus Res       Date:  1985-04       Impact factor: 3.303

9.  Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

Authors:  Y Matsuura; R D Possee; H A Overton; D H Bishop
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

10.  Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.

Authors:  D Naniche; G Varior-Krishnan; F Cervoni; T F Wild; B Rossi; C Rabourdin-Combe; D Gerlier
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

View more
  18 in total

1.  Fish rhabdovirus cell entry is mediated by fibronectin.

Authors:  M Bearzotti; B Delmas; A Lamoureux; A M Loustau; S Chilmonczyk; M Bremont
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein.

Authors:  Y Jacob; H Badrane; P E Ceccaldi; N Tordo
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders.

Authors:  H Badrane; N Tordo
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro.

Authors:  P Coulon; J P Ternaux; A Flamand; C Tuffereau
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity.

Authors:  H Badrane; C Bahloul; P Perrin; N Tordo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein.

Authors:  T Mebatsion
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 7.  Rabies virus receptors.

Authors:  Monique Lafon
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

8.  Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.

Authors:  K Morimoto; D C Hooper; S Spitsin; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Cellular uptake mechanism and therapeutic utility of a novel peptide in targeted-delivery of proteins into neuronal cells.

Authors:  Ailing Fu; Zizhen Zhao; Feiyan Gao; Miaomiao Zhang
Journal:  Pharm Res       Date:  2013-05-15       Impact factor: 4.200

10.  Chimeric lyssavirus glycoproteins with increased immunological potential.

Authors:  C Jallet; Y Jacob; C Bahloul; A Drings; E Desmezieres; N Tordo; P Perrin
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.